#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Behcet's syndrome Central nervous system lymphoma Advanced systemic mastocytosis Chronic myelomonocytic leukaemia Neuropathy peripheral Hepato-lenticular degeneration Still's disease Hormone-dependent prostate cancer Primary amyloidosis Hereditary spastic paraplegia Anti-myelin-associated glycoprotein associated polyneuropathy Focal segmental glomerulosclerosis Autologous haematopoietic stem cell transplant Ewing's sarcoma Lip and/or oral cavity cancer More trials…

    Learn about Rare Diseases

    Acute respiratory distress syndrome – Diagnostics Wolfram syndrome Haemophilia B with anti factor IX – Diagnostics MELAS syndrome – Treatment Mantle cell lymphoma stage III – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Basic Information Phenylketonuria – Trials in Disease Alexander disease – Diagnostics Mitochondrial myopathy – Trials in Disease Cystic fibrosis lung – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tecaginlimab Sparsentan Gad20-209-Fsp-A2 Antipsychotics Glucagon Avatrombopag SEVABERTINIB Cyanocobalamin GSK5458514 AGALSIDASE BETA Doxorubicin Hydrochloride Levoleucovorin TAGRAXOFUSP ZIMISLECEL Felis Domesticus (555) Brodalumab Glucose, Anhydrous Telitacicept Eribulin Navtemadlin More therapies…

    Learn about Your Condition

    Anal squamous cell carcinoma HIV infection Angiosarcoma non-metastatic Round cell liposarcoma Transient ischaemic attack Haemofiltration Conjunctivitis Atrial flutter Pharyngeal cancer stage II Renal transplant Niemann-Pick disease Peyronie's disease Colorectal cancer stage IV HER2 positive breast cancer Laryngeal cancer stage I More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopital LARREY

Hopital LARREY

24 Chemin de POUVOURVILLE, Toulouse, 31000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Pembrolizumab and Chemotherapy with Radiation for Advanced Non-Small Cell Lung Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Paclitaxel
    France
  • Study on the Effectiveness and Safety of Masitinib for Patients with Severe Systemic Mastocytosis Unresponsive to Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Mastocytosis
    Investigated Drugs:
    • Masitinib
    France Poland Spain
  • Study on Masitinib for Patients with Severe Mast Cell Activation Syndrome Unresponsive to Treatment

    Not recruiting

    2 1
    Investigated Diseases:
    • Mast cell activation syndrome
    Investigated Drugs:
    • Masitinib
    France

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!